Results of the psychometric instruments applied to patients with AAU at the initial visit (before start of treatment) and the follow-up visit (8 weeks later), as well as those of the controls
| Controls | AAU patients | Females | Males | |
|---|---|---|---|---|
| BDI initial visit | 4 (4)* | 11 (7) | 12 (7) | 10 (6) |
| BDI f/u visit | 4 (5) | 7 (6) | 6 (4) | 8 (7) |
| ZMS initial visit | 11 (10) | 30 (14)* | 30 (12) | 29 (16) |
| ZMS f/u visit | 9 (8) | 20 (12)* | 21 (9) | 19 (14) |
| SF8-MCS | 55 (6) | 44 (11)* | 42 (11) | 44 (11) |
| SF8-PCS | 52 (8) | 37 (7)* | 37 (5) | 37 (8) |
| VAS initial visit | 1 (1) | 59 (22) | 69 (20)* | 53 (21) |
| VAS f/u visit | 1 (1) | 2 (1)* | 2 (1) | 2 (1) |
BDI score interpretation: ‘not depressed’ (0–9 points), ‘minimal depressive mood’ (10–18 points), and ‘clinically relevant depressive mood’ (19–63 points). ZMS score interpretation: ‘euphoric’ (0–6 points), ‘well-balanced ‘(7–16 points), ‘aggrieved’ (17–26 points), ‘mildly to moderately depressive’ (27–41 points), ‘pronounced to extremely depressive’ (42–56 points). Concerning the SF-8, healthy persons should reach a mean score of 50±10. A higher/lower score indicates a better/worse level of functioning or general health.
Data are given as means, SD relating to groups is given in parentheses.
*Significance at p<0.05.
AAU, acute anterior uveitis; BDI, Beck depression inventory; f/u, follow-up; SF8-MCS, Short Form 8-health survey mental component summary; SF8-PCS, Short Form 8-health survey physical component summary; VAS, visual analogue scale pain; ZMS, Zerssen Mood Scale.